Market Herald logo

Subscribe

Be the first with the news that moves the market
  • JKS Resources (JKS) has completed its maiden drill program on its Sowchea Property in B.C.’s Omineca Mining Division
  • The drill program is spread across 12 holes totalling 272 metres. Due to the overburden being more significant than anticipated, the company completed fewer drill holes due to the length required to reach the bedrock
  • Assays were delivered to the independent laboratory and results will be reported when received
  • JKS Resources Inc. (JKS) is unchanged, trading at C$0.32 per share at 11 am ET

JKS Resources (JKS) has completed its maiden drill program on its Sowchea Property.

The drill program is spread across 12 holes totalling 272 metres. Due to the overburden being more significant than anticipated, the company completed fewer drill holes due to the length required to reach the bedrock.

Assays were delivered to the independent laboratory and results will be reported when received.

JKS Resources is engaged in the exploration of mineral properties, focusing on gold. It holds an interest in the Sowchea Property, which consists of three mineral claims covering approximately 22.8 sq. km. in the Omineca Mining Division of Central British Columbia. JKS also holds an option to acquire a 100 per cent interest in the Sowchea Property.

JKS Resources Inc. (JKS) is unchanged, trading at C$0.32 per share at 11 am ET.

More From The Market Herald

" ParcelPal (CSE:PKG) relaunches a new and improved mobile application

ParcelPal Logistics (PKG) will relaunch its mobile delivery application on a rolling basis over the coming months.

" Puma Exploration (TSXV:PUMA) confirms mineralization

Puma Exploration (PUMA) is confirming mineralization at its Williams Brook Gold Project in Northern New Brunswick.
Flying Nickel Mining

" Flying Nickel (TSXV:FLYN) confirms platinum, palladium, gold mineralization

Flying Nickel Mining (FLYN) is confirming, it uncovered gold mineralization from the most-recent drill program on its Minago Nickel PGM Project.

" NervGen Pharma (TSXV:NGEN) releases year-end operational highlights

NervGen Pharma (NGEN) reports 2022 year-end operational highlights and looks to start a phase 1b/2a clinical trial in Q3 2023.